Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy Citigroup Inc.

Crinetics Pharmaceuticals Inc
Start price
€57.00
14.11.24 / 50%
Target price
€70.14
14.11.25
Performance (%)
-36.14%
End price
€36.40
15.11.25
Summary
This prediction ended on 15.11.25 with a price of €36.40. Massive losses of -36.14% were the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Crinetics Pharmaceuticals Inc 0.797% 0.797% 198.049%
iShares Core DAX® 0,63 % 4,95 % 8,66 %
iShares Nasdaq 100 1,16 % -1,16 % 26,82 %
iShares Nikkei 225® 2,36 % -1,35 % 48,19 %
iShares S&P 500 0,63 % 1,38 % 22,99 %

Comments by Citigroup_Inc_ for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -36.14%
Target price 70.137
Change
Ends at 14.11.25

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Citigroup Inc. from $70.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat

Citigroup Inc. 
0
Report Share
14.11.24
In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) -36.14%
Target price 70.137
Change
Ends at 14.11.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
15.11.25